Export

EP Vantage wins Commentator of the Year Award at European Mediscience Awards

Date June 24, 2011

EP Vantage, part of EvaluatePharma, was presented with the coveted Commentator of the Year Award at the European Mediscience Awards on June 22, 2011.

The award, which honours clear and concise commentary in the pharma and biotech sector, can be given to analysts, journalists, columnists, research houses or specialist websites dedicated to providing sharp, perceptive and penetrating commentary.

The EP Vantage team – Lisa Urquhart, Amy Brown, Christian Glennie and Jonathan Gardner – beat a strong field that included analysts and fellow journalists to claim the prize.

Speaking about the achievement Jonathan de Pass, chief executive of EvaluatePharma, said: “I’m thrilled that the EP Vantage team have won the European Mediscience 2011 Commentator of the Year award".

"The life-science industry is well served for commentary by several long-established publications and by many securities analysts so this is all the more an incredible achievement given that EP Vantage has been going for less than four years. After twice being runners-up for this award, this is well-deserved recognition for the team".

The European Mediscience Awards Dinner, sponsored by Matrix, is the largest annual gathering of quoted biotech and life sciences companies in Europe. It celebrates the best in the sector and highlights the achievements of individuals and companies. The event recognises the importance of access to the capital markets to fund growth and innovation and is attended by specialist investors, advisors, media and analysts.

Now in its 10th year, the winners were announced at a dinner which was held at the Hotel Intercontinental, London W1 on Wednesday 22 June 2011.

http://www.mediscience-event.co.uk/winners/

This content is written, edited and published by EP Vantage and is distributed by Evaluate Ltd. All queries regarding the content should be directed to: news@epvantage.com

EP Vantage is a unique, forward-looking, news analysis service tailored to the needs of pharma and finance professionals. EP Vantage focuses on the events that will define the future of companies, products and therapy areas, with detailed financial analysis of events in real-time, including regulatory decisions, product approvals, licensing deals, patent decisions, M&A.

Drawing on Evaluate, an industry-leading database of actual and forecast product sales and financials, EP Vantage gives readers the insight to make value-enhancing decisions.

EP Vantage SM ©2017 EP Vantage Ltd